Skip to content

Biologic Glue for First Degree Perineal Tears

Randomized Control Trial for the Comparison of Biologic Glue Versus Suturing for First Degree Perineal Tears

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00746707
Enrollment
102
Registered
2008-09-04
Start date
2008-09-30
Completion date
2011-08-31
Last updated
2011-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Grade 1 Perineal Tears

Keywords

adhesive glue, perineal tear, suture

Brief summary

The use of octyl-2-cyanoacrylate adhesive glue is not inferior to traditional suturing for first degree perineal tears repair

Detailed description

This is a prospective randomized trial, comparing the use of octyl-2-cyanoacrylate adhesive glue to traditional suturing, for the repair of first degree perineal tears.

Interventions

DEVICE1. Dermabond Topical Skin Adhesive 2-Octyl Cyanoacrylate

adhesive of perineal tears

PROCEDURE3. traditional suturing with vicryl rapid 2X0

suturing of perineal tears grade one with vicryl rapid 2X0

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* women after instrumental or normal vaginal delivery with a diagnosis of first degree perineal tears

Exclusion criteria

* excessive bleeding, * chronic steroid treatment, * immunosuppressive treatment, * active infection, * allergy to Dermabond or Histoacryl

Design outcomes

Primary

MeasureTime frame
Functional and cosmetic evaluation of perineal tear area.At least six weeks after birth

Secondary

MeasureTime frame
Assessment of pain at least six weeks after deliveryAt least six weeks after delivery

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026